<DOC>
	<DOCNO>NCT02766764</DOCNO>
	<brief_summary>Two hundred thirty woman expect poor ovarian response undergo IVF/ICSI randomly divide 2 equal group use computer generate random number . Group 1 receive DHEA 25 mg ( DHEA 25mg , Natrol , USA ) t.d.s 12 week start IVF/ICSI cycle addition Growth hormone ( GH ; Somatotropin , Sedico , Egypt ) 4 IU day 6 human menopausal gonadotropin ( hMG ) stimulation daily dose 2.5 mg subcutaneous ( sc ) day human chorionic gonadotropin ( hCG ) trigger Group 2 receive oral placebo t.d.s . daily 12 week ICSI addition sc placebo similar GH daily day 6 stimulation day hCG trigger .</brief_summary>
	<brief_title>Combined Dehydropeiandrosterone Growth Hormone Women With Expected Poor Ovarian Response Undergoing ICSI</brief_title>
	<detailed_description>The study conduct Cairo university hospital Dar Al-Teb Infertility Assisted conception center , Giza Egypt . All patient evaluate expected ovarian response . Patients fulfil Bologna criterion definition poor ovarian response invite participate study sign inform consent form . Two hundred thirty woman expect poor ovarian response ( POR ) undergo IVF/ICSI randomly divide 2 equal group use computer generate random number . Group 1 receive DHEA 25 mg ( DHEA 25mg , Natrol , USA ) t.d.s daily 12 week start IVF/ICSI cycle addition GH Growth hormone ( Somatotropin , Sedico , Egypt ) 4 IU day 6 hMG stimulation daily dose 2.5 mg SC day hCG trigger Group 2 receive oral placebo t.d.s . daily 12 week ICSI addition placebo similar GH daily day 6 stimulation day hCG trigger . Patients include study subject full history take clinical examination . On second day menstruation serum FSH , LH , Prolactin Oestradiol assess antral follicular count ( AFC ) assess use vaginal ultrasound scan . AFC define number follicle measure 3-10mm . All patient gonadotropin antagonist protocol Human menopausal gonadotrophin ( HMG ) stimulation day ( Human chorionic gonadotrophin ( HCG ) administration . On second day menstruation serum FSH , LH , Prolactin Oestradiol assess antral follicular count ( AFC ) assess use vaginal ultrasound scan . AFC define number follicle measure 3-10mm . The stimulation protocol start day 2 use 450-300 IU HMG ( Merional速 IBSA , Lugano , Switzerland ) GnRH antagonist , cetrorelix ( Cetrotide速 Merck Serono , Darmstadt , Germany ) 0.025 mg daily . Gonadotropins administer 4 5 day , dose adjust accord ovarian response . The ovarian response monitor transvaginal ultrasound serum E2 level . When three follicle reach maximum diameter 16 mm , highly purify HCG 5000 10,000 IU ( Choriomon 速IBSA ) administer . The procedure cancel less 3 follicle 16 mm size present 12 day start gonadotropin despite dos reach 450 IU . The cycle also cancel risk ovarian hyperstimulation like massive ovarian enlargement serum estradiol exceed 3000pg/L Transvaginal oocyte retrieval perform 34-36 h administration HCG . Oocytes fertilized either via IVF ICSI base couple 's history . Fertilization assess 16-18 h IVF ICSI . Embryos transfer Day 3 5 . Vaginal tablet contain progesterone ( Prontogest速 IBSA ) 400 mg/day give fertilization confirm . A pregnancy test do 2 week embryo transfer . For patient positive pregnancy test , progesterone continue additional 4 week . Clinical pregnancy define Visualization intrauterine gestational sac 5 week embryo transfer . And ongoing pregnancy define sonographic confirmation fetal heart pulsation 12 week . Sample size calculation : The researcher plan study independent case control 1 control ( ) per case . Kotb et al find ongoing pregnancy rate woman undergo IVF/ICSI receive DHEA expect POR accord Bologna criterion 0.285 versus 0.128 control group . Assuming add GH DHEA increase ongoing pregnancy rate , researcher need study 103 case patient 103 control patient able reject null hypothesis exposure rate case control equal probability ( power ) 0.8 . The researcher add 12 patient arm accounting miss data loss follow . The Type I error probability associate test null hypothesis 0.05 . The researcher use uncorrected chi-squared statistic evaluate null hypothesis .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Women undergo ICSI expect poor ovarian response accord Bologna criterion Body mass index &gt; 35 Kg/m2 . Women single ovary . Allergy DHEA GH . Diabetic woman insulin insulin lower DHEA level might reduce effectiveness</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>